JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
CRH
CRH
$54.5B
| $3.74M | ﹤0.01% |
107,513
-161,825
| -60% | -$6.3M |
2015 Q2
28 quarters
|
|
2902
Southside Bancshares
SBSI
$916M
| $3.74M | ﹤0.01% |
99,845
+14,521
| +17% | +$565K |
2014 Q4
30 quarters
|
|
2903
ADT
ADT
$4.57B
| $3.72M | ﹤0.01% |
604,277
+290,879
| +93% | +$2.03M |
2018 Q1
17 quarters
|
|
2904
Veeco
VECO
$3.51B
| $3.72M | ﹤0.01% |
191,544
+20,373
| +12% | +$452K |
2016 Q3
23 quarters
|
|
2905
Worthington Enterprises
WOR
$2.97B
| $3.71M | ﹤0.01% |
136,379
-180,673
| -57% | -$5.24M |
2013 Q2
36 quarters
|
|
2906
Tortoise North American Pipeline ETF
TPYP
$837M
| $3.71M | ﹤0.01% |
152,771
-25,427
| -14% | -$670K |
2019 Q3
11 quarters
|
|
2907
Schneider National
SNDR
$5.77B
| $3.7M | ﹤0.01% |
165,515
+58,421
| +55% | +$1.35M |
2017 Q2
20 quarters
|
|
|
SPR
2908
DELISTED
Spirit AeroSystems
SPR
| $3.7M | ﹤0.01% |
126,347
-1,763,384
| -93% | -$63.1M |
2013 Q2
36 quarters
|
|
2909
Kodiak Sciences
KOD
$5.94B
| $3.7M | ﹤0.01% |
484,441
+79,715
| +20% | +$560K |
2018 Q4
14 quarters
|
|
|
MGI
2910
DELISTED
MoneyGram International, Inc. New
MGI
| $3.7M | ﹤0.01% |
369,636
+296,217
| +403% | +$2.98M |
2020 Q2
8 quarters
|
|
2911
PUT
Allstate
ALL
$56.6B
| $3.69M | ﹤0.01% |
29,100
+26,100
| +870% | +$3.42M |
2022 Q1
1 quarter
|
|
|
TUFN
2912
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $3.69M | ﹤0.01% |
293,539
-10,002
| -3% | -$124K |
2019 Q3
11 quarters
|
|
|
MRTX
2913
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.67M | ﹤0.01% |
54,729
+26,463
| +94% | +$1.68M |
2018 Q2
16 quarters
|
|
|
MEKA
2914
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $3.67M | ﹤0.01% |
371,086
+257,386
| +226% | +$2.62M |
2021 Q3
3 quarters
|
|
2915
Unisys
UIS
$166M
| $3.67M | ﹤0.01% |
304,701
+14,289
| +5% | +$201K |
2013 Q2
36 quarters
|
|
2916
PUT
Sunrun
RUN
$1.86B
| $3.67M | ﹤0.01% |
156,900
+6,900
| +5% | +$166K |
2022 Q1
1 quarter
|
|
2917
PUT
Tapestry
TPR
$23.6B
| $3.66M | ﹤0.01% |
120,000
| – | – |
2022 Q1
1 quarter
|
|
|
CINC
2918
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $3.66M | ﹤0.01% |
194,345
+188,904
| +3,472% | +$3.62M |
2022 Q1
1 quarter
|
|
|
HJEN
2919
DELISTED
Direxion Hydrogen ETF
HJEN
| $3.66M | ﹤0.01% |
250,000
| – | – |
2021 Q1
5 quarters
|
|
|
FHLT
2920
DELISTED
Future Health ESG Corp. Common stock
FHLT
| $3.65M | ﹤0.01% |
+369,073
| New | +$3.65M |
2022 Q2
0 quarters
|
|
|
BBBY
2921
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.64M | ﹤0.01% |
+733,100
| New | +$8.53M |
2022 Q2
0 quarters
|
|
2922
Peoples Bancorp
PEBO
$1.35B
| $3.64M | ﹤0.01% |
136,778
+48,145
| +54% | +$1.37M |
2016 Q4
22 quarters
|
|
2923
WesBanco
WSBC
$3.65B
| $3.63M | ﹤0.01% |
114,561
+11,319
| +11% | +$373K |
2013 Q2
36 quarters
|
|
2924
PUT
Snap
SNAP
$9.44B
| $3.62M | ﹤0.01% |
275,900
-1,691,800
| -86% | -$38.6M |
2020 Q3
7 quarters
|
|
|
BITE
2925
DELISTED
Bite Acquisition Corp.
BITE
| $3.62M | ﹤0.01% |
368,796
-312,219
| -46% | -$3.06M |
2021 Q2
4 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.